KZ
Kevin Zhuge
Executive Director Of Facilities & Engineering at Transcenta
View Kevin's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Executive Director Of Facilities & Engineering
Jul 2019 - Present · 5 years and 6 months
Jan 2018 - Present · 7 years
Executive Director Of Facilities & Engineering
Jul 2019 - Present · 5 years and 6 months
Senior Director Of Facilities & Engineering
Jan 2018 - Jul 2019 · 1 years and 6 months
Company Details
201-500 Employees
Transcenta is a clinical stage biopharmaceutical company that fully integrates antibody-based biotherapeutics discovery, research, development and manufacturing. On September 29, 2021, Transcenta was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 06628. Transcenta has established global footprint, with Headquarters and Discovery, Clinical and Translational Research Center in Suzhou, Process and Product Development Center and Manufacturing Facility in Hangzhou, and Clinical Development Centers in Beijing, Shanghai and Guangzhou in China and in Princeton, US, and External Partnering Center in Boston and Los Angeles, US. Transcenta is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. For more information, please visit www.transcenta.com.
Year Founded
2019
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
Hangzhou, Zhejiang, CN
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Kevin Zhuge in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.